Related by context. All words. (Click for frequent words.) 70 neurodegenerative diseases 69 neurodegenerative disorders 69 neurodegenerative disease 67 neurodegeneration 67 neurological diseases 63 neurodegenerative disorder 63 excitotoxicity 62 neuronal dysfunction 62 autoimmune 62 degenerative diseases 61 Parkinson disease Alzheimer disease 61 muscular dystrophies 61 protein misfolding 61 neuro degenerative diseases 61 Neurodegenerative diseases 60 autoimmune diseases 60 degenerative disorders 60 pathophysiologic 59 motor neuron degeneration 59 Prion diseases 59 synaptogenesis 59 progressive neurodegenerative disorder 59 neurological disorders 59 neuroprotective 59 amyotrophic lateral sclerosis ALS 59 neuroprotection 58 mitochondrial dysfunction 58 fibrotic disease 58 Wnt signaling pathway 58 lysosomal storage diseases 58 neuroinflammation 58 mGluR2 NAM 58 diabetic nephropathy 58 pathophysiological 58 Friedreich ataxia 58 renal fibrosis 58 amyloid beta proteins 58 immune mediated 57 engineered RAP peptides 57 neuronal degeneration 57 fibrotic diseases 57 rheumatoid arthritis multiple sclerosis 57 lung fibrosis 57 nerve degeneration 57 TMEM#B 57 progressive neurodegenerative 57 skeletal muscle weakness 57 alpha synuclein protein 57 fatal neurodegenerative 57 neuroinflammatory 56 Alzheimer disease 56 protein tau 56 neuropsychiatric disorders 56 Alzheimers disease 56 cardiac hypertrophy 56 psoriasis rheumatoid arthritis 56 Huntingtons disease 56 Oxidative stress 56 neuropsychiatric diseases 56 NMDA receptor 56 neurofibrillary tangles 56 proliferative diseases 56 cachexia 56 oncogenesis 56 mutated protein 56 airway remodeling 56 MELAS 56 Alzheimer disease Parkinson disease 56 Hedgehog pathway 56 pathological hallmark 56 axonal damage 56 Alzheimer Disease AD 56 autoimmunity 56 lupus multiple sclerosis 56 RNA silencing 56 neuro inflammatory 56 protein misfolding diseases 56 inflammatory cascade 56 neurogenic 55 autoimmune disorders 55 MAP kinase pathway 55 SOD1 55 metabolic disorders 55 tissue fibrosis 55 Hutchinson Gilford Progeria Syndrome 55 fibrotic disorders 55 SOD1 gene 55 neuroprotective properties 55 Oxidative damage 55 inflammatory diseases 55 apoptotic pathway 55 progressive degenerative 55 kidney urologic 55 COX2 55 ADDLs 55 Autoimmune diseases 55 biochemical mechanisms 55 CB2 receptor 55 excitotoxic 55 epilepsy Parkinson disease 55 Alzheimer disease AD 55 facioscapulohumeral muscular dystrophy 55 anemias 55 Parkinson Alzheimer 55 muscular dystrophy cystic fibrosis 55 chronic inflammation 55 pathogenesis 55 myeloproliferative neoplasms 55 genomic instability 55 anti amnesic 55 RNAi therapeutic targeting 55 Hedgehog signaling pathway 55 beta amyloid peptide 55 tauopathies 55 Parkinsons disease 55 immune dysregulation 55 neuroprotective effects 55 neuron degeneration 55 amyloid beta plaques 55 degenerative 55 Vascular Endothelial Growth 55 cardiovascular metabolic 55 prostaglandin D2 55 neuronal nicotinic receptors NNRs 55 atherosclerosis 55 amyloid deposits 55 chronic inflammatory 54 autoinflammatory diseases 54 inflammatory disorders 54 progressive degeneration 54 TTR amyloidosis 54 glutamate receptors 54 oxidative stress 54 serotonin receptor 54 familial adenomatous polyposis 54 neurotrophic 54 LRRK2 54 hedgehog pathway 54 signaling cascades 54 cellular senescence 54 small molecule inhibitors 54 pharmacological chaperone 54 Retinitis pigmentosa 54 neuronal cell 54 transient receptor 54 lysosomal 54 AT1R 54 amyloid formation 54 inflammatory bowel diseases 54 bioactive lipids 54 TGF β 54 hematologic disorders 54 inherited neurodegenerative disorder 54 retinal degeneration 54 Tß4 54 anticancer therapeutics 54 fibrotic 54 tau protein 54 myeloproliferative diseases 54 JAK3 54 HDAC inhibition 54 inherited retinal 54 ischemic diseases 54 protein kinase C 54 amyloidogenic 54 spinocerebellar ataxia 54 immuno modulatory 54 γ secretase 54 amyloid proteins 54 IL 1ß 54 tumorigenesis 54 demyelination 54 deacetylase inhibitors 54 p# pathway 54 cell signaling pathways 54 chronic autoimmune 54 neurotransmission 54 huntingtin protein 54 GSK3 54 beta amyloid proteins 54 secondary hyperparathyroidism 54 hyperphosphorylation 54 cardiometabolic disorders 53 neurological 53 neurologic diseases 53 neurodegenerative illnesses 53 degenerative neurological 53 phosphoinositide 3 53 dysregulated 53 serine protease 53 malignant transformation 53 non alcoholic steatohepatitis 53 intracellular protein 53 amyloidosis 53 diabetic kidney 53 induce apoptosis 53 progranulin protein 53 synaptic transmission 53 spongiform encephalopathies 53 amyloid beta peptide 53 axonal degeneration 53 Hedgehog signaling 53 beta amyloid accumulation 53 FTLD 53 SIRT1 gene 53 myeloproliferative disorders 53 beta amyloid plaques 53 molecular mechanisms underlying 53 small molecule defensin 53 lysosomal storage disorders 53 cellular pathways 53 immuno inflammatory diseases 53 C5aR 53 anti fibrotic 53 myopathies 53 fronto temporal dementia 53 pro angiogenic 53 psoriasis psoriatic arthritis 53 autoimmune disease 53 AA amyloidosis 53 osteoclast activity 53 NMDA receptors 53 immune modulator 53 inflammatory bowel disease 53 Cancer cachexia 53 Symadex 53 interferon pathway 53 Squalamine 53 #beta HSD1 53 neuro degenerative disease 53 immunological 53 neuro protective 53 biologic therapeutics 53 romazarit 53 mitochondrial mutations 53 metabolic disorder 53 Raf MEK ERK 53 epigenetic alterations 53 Inflammatory bowel diseases 53 pathological hallmarks 53 misfolding 53 motor neuron diseases 53 vascular inflammation 53 neurological degeneration 53 c myc gene 53 neuroprotective therapies 53 degenerative neurological diseases 53 Apoptosis 53 misfolded proteins 53 hyperparathyroidism 53 LPA1 receptor 53 neurotransmitter glutamate 53 transgenic mouse models 53 Smad3 53 rheumatoid arthritis psoriasis 53 NF kB pathway 53 neurodevelopmental disorders 53 GABA aminotransferase 53 cholinergic neurons 53 telomere dysfunction 53 proliferative disorders 53 Abeta# 53 insoluble plaques 53 Hh pathway 53 Hutchinson Gilford progeria 53 remyelination 53 acetylcholinesterase 53 pathophysiology 53 Janus kinase 53 ataxias 53 breast cancer metastasis 53 Friedreich Ataxia FRDA 53 mitogen activated protein kinase 53 neuro degenerative disorders 53 VEGF inhibitors 53 Misfolded proteins 52 Alzheimer Parkinson 52 microglial cells 52 Gleevec inhibits 52 glial cell 52 HGPS 52 synaptic function 52 sortilin 52 neurologic 52 metabotropic glutamate receptors 52 incurable neurodegenerative disease 52 hormone gastrin 52 Notch1 52 glial derived neurotrophic 52 biological pathways 52 autoimmune uveitis 52 pathogenic mechanisms 52 myeloproliferative 52 ENaC 52 leukotriene pathway 52 cardiac fibrosis 52 Amyotrophic Lateral Sclerosis ALS 52 mutant huntingtin 52 beta amyloid peptides 52 advanced glycation end 52 systemic inflammation 52 cancer cachexia 52 Wnt signaling 52 amyloid plaque 52 immunological diseases 52 tumor suppressor genes 52 potent inhibitors 52 beta secretase inhibitors 52 peroxisomal 52 underlying pathophysiology 52 arthritis RA 52 lysosomal storage disease 52 progressive neurodegenerative disease 52 Parkinson disease PD 52 JAK2 enzyme 52 HDAC 52 siRNA therapeutics 52 identify protein biomarkers 52 selective inhibition 52 motor neuron disease 52 TÎ ² 4 52 uPA 52 Factor VEGF 52 Systemic lupus erythematosus SLE 52 myelodysplasia 52 molecular underpinnings 52 tumor suppressor protein 52 MGUS 52 amyloid protein 52 disease modifying 52 liver fibrosis 52 anti angiogenesis 52 antitumor 52 sphingolipid 52 V#F mutation 52 systemic juvenile idiopathic 52 fatal neurodegenerative disorder 52 ophthalmic diseases 52 lipid metabolism 52 Treg cell 52 neuroendocrine 52 RANK ligand 52 molecular abnormalities 52 inverse agonist 52 fibrogenesis 52 inhibit angiogenesis 52 systemic amyloidosis 52 MMP inhibitors 52 apoE 52 neuronal 52 small molecule activators 52 Psoriatic arthritis 52 Glucocorticoid 52 huntingtin gene 52 ibudilast 52 Stargardt Macular Dystrophy SMD 52 VEGF receptor 52 β amyloid 52 Diabetic neuropathy 52 allergic inflammation 52 MELAS syndrome 52 LRRK2 mutations 52 LPA1 52 Aviptadil 52 abnormal angiogenesis 52 Wnt pathway 52 myotonic dystrophy 52 Dysregulation 52 neurodegenerative disorder characterized 52 antiviral compounds 52 GPR# [002] 52 mGluR5 antagonist 52 PDE# inhibitors 52 amyloid peptide 52 underlying molecular mechanisms 52 CYT# potent vascular disrupting 52 hematologic diseases 52 degenerative disorder 52 degenerative neurological condition 52 calcineurin 52 Duchenne muscular dystrophy DMD 52 molecular mechanisms 52 molecularly targeted 52 β catenin 52 galanin 52 activate SIRT1 52 anti angiogenic 52 sphingolipids 52 severe malignant osteopetrosis 52 reperfusion injury 52 hypophosphatasia 52 mimetics 52 GGTase 52 nonsense mutation 52 chromosomal translocations 52 fibrosis 52 histone deacetylase HDAC 52 debilitating autoimmune 52 Clusterin 52 mGluR4 activation 52 CCR1 52 inflammatory demyelinating 52 cholinergic 52 BRAF gene 52 IRAK1 52 podocyte 52 IL #R 52 GSK3B 52 Alu RNA 52 mGluR 52 glucagon receptor 52 receptor subtype 52 pathophysiological effects 52 PDGFR 52 innate immune 52 HDAC inhibitors 52 angiogenesis 52 chemokines 52 CNS disorders 52 cholesterol metabolism 52 cognitive dysfunction 52 demyelinating diseases 52 Leber Congenital Amaurosis LCA 52 antibody mediated 51 histone deacetylase inhibitors 51 TTR gene 51 molecular chaperones 51 inherited retinal degeneration 51 tiapamil 51 p# activation 51 nicotinic receptors 51 plasma kallikrein 51 druggable target 51 frontotemporal dementia 51 neurotrophic factors 51 lipofuscin 51 Brugada Syndrome 51 neurogenesis 51 cytoprotective 51 neurite outgrowth 51 protein alpha synuclein 51 rheumatoid arthritis Crohn disease 51 P#X# 51 infantile NCL 51 neuronal function 51 protein homeostasis 51 atypical hemolytic uremic syndrome 51 neurologic disorder 51 Angiotensin II 51 neurologic disorders 51 incurable neurological disorder 51 dyskeratosis congenita 51 cystic fibrosis chronic pancreatitis 51 toxic amyloid beta 51 atherosclerotic disease 51 glucocorticoid receptor 51 inflammasome 51 adult neurogenesis 51 RANKL 51 ERK signaling 51 Factor VIIa 51 renal disease 51 dopaminergic 51 intracellular accumulation 51 rheumatologic 51 phosphatidylinositol 3 51 neuroendocrine cancers 51 inherited neurological disorder 51 matrix metalloproteinases MMPs 51 atherosclerotic 51 endocrine diseases 51 CTGF 51 skeletal sarcomere 51 carcinogenesis 51 factor GDNF 51 mitotic catastrophe 51 superoxide dismutase 51 neuro degeneration 51 proinflammatory 51 SIRT3 51 Behcet uveitis 51 neurogenerative diseases 51 targeted radiotherapeutics 51 mesenchymal cell 51 JNK pathway 51 Bardet Biedl Syndrome 51 Lu AA# 51 PPAR γ 51 E#F# 51 IGF 1R 51 progerin 51 immunomodulatory 51 Stapled Peptide 51 FGFR 51 MMP2 51 erythematosus 51 prion diseases 51 Alport syndrome 51 Abeta protein 51 amyloids 51 neuronal plasticity 51 Src kinase 51 peptibody 51 degenerative brain 51 Retinopathy 51 proNGF 51 nonsense mutations 51 RANK Ligand 51 organ transplant rejection 51 autoimmune encephalitis 51 Amyotrophic lateral sclerosis 51 COX enzymes 51 leukotrienes 51 autoimmune inflammatory 51 ABCA1 51 DITPA 51 c MET 51 FMRP protein 51 commercializes innovative biopharmaceuticals 51 modulate gene expression 51 neuronal differentiation 51 intracellular pathways 51 amyloid cascade 51 multiple sclerosis psoriasis 51 presymptomatic 51 cytokine signaling 51 glomerulonephritis 51 peroxisome proliferator activated 51 investigational compounds 51 jasmonate 51 immune modulation 51 histone deacetylation 51 MAPK pathway 51 hereditary disorder 51 derived neurotrophic factor 51 Hsp# inhibition 51 Chronic Inflammatory Demyelinating Polyneuropathy 51 dysregulation 51 protein kinases 51 neuromuscular junction 51 membrane receptors 51 inherited neurodegenerative 51 malignant lymphomas 51 kinase pathway 51 kinase PI3K pathway 51 molecular pathway 51 ADAMTS# 51 Myotonic dystrophy 51 PDE7 51 LRP5 51 amyloid ß 51 PI3K/mTOR 51 DLX5 51 Muscular dystrophy 51 Autoimmune disorders 51 diagnostic biomarkers 51 regulating gene expression 51 retinoid X 51 TNFR 51 corticobasal degeneration 51 molecular pathways 51 amyloid deposition 51 neurobiological 51 immunoregulatory 51 AA Amyloidosis 51 interleukins 51 olfactory dysfunction 51 mutant protein 51 mitochondrial disorders 51 tyrosine kinases 51 diabetic retinopathy DR 51 Pseudomonas aeruginosa infections 51 NAGS deficiency 51 mtDNA mutations 51 macular degeneration diabetic retinopathy 51 SCD1 51 neuronal apoptosis 51 leukocyte adhesion 51 alpha synuclein 51 resolvins 51 hereditary spastic paraplegia 51 p# inhibitor 51 Glycosylation 51 synovial cells 51 rare autosomal recessive 51 VIPR2 50 Cystic fibrosis CF 50 LIS1 50 Alzheimer pathology 50 gamma secretase 50 glutamatergic 50 NeuroTrans TM 50 non coding RNA 50 Fc fusion protein 50 cardio renal 50 glycolipids 50 monogenic 50 osteopontin 50 TXNIP 50 sarcopenia 50 Peutz Jeghers syndrome 50 nicotinic alpha 7 50 podocytes 50 susceptibility gene 50 Hutchinson Gilford Progeria 50 polyglutamine diseases 50 Phylomer ® 50 cognitive deficits 50 choroidal neovascularization 50 cystic fibrosis transmembrane conductance 50 upregulating 50 dendritic spine 50 IL#R 50 NTDDS 50 causative genes 50 axon regeneration 50 inhibit metastasis 50 idiopathic pulmonary fibrosis IPF 50 apoptotic 50 #ß HSD1 50 retinitis pigmentosa RP 50 acetylcholine receptor 50 PI3K 50 nitric oxide synthase 50 eotaxin 50 Dr. Bezprozvanny 50 acetylcholinesterase AChE 50 sirtuin therapeutics 50 mGluR4 50 Htt 50 nicotinic receptor 50 alpha#beta# 50 immunodeficiencies 50 IAP inhibitor 50 inflammation thrombosis oncology 50 incretin 50 hemoglobinopathies 50 myelination disorders 50 familial ALS 50 telomere shortening 50 coagulation cascade 50 immuno inflammatory 50 debilitating neurodegenerative disorder 50 tau tangles 50 humanized monoclonal antibodies 50 dominantly inherited 50 ATTR PN 50 mGluRs 50 NNRs 50 neovascular 50 OXIGON TM 50 Genetic variations 50 prostate carcinogenesis 50 neurotrophic factor 50 polyamines 50 myelofibrosis polycythemia vera 50 debilitating neurodegenerative 50 protein clumps 50 MAP kinases 50 Sirtuins 50 cMET 50 histone deacetylase 50 tau aggregates 50 gliosis 50 mitochondrial decay 50 senile plaques 50 beta catenin protein 50 Amyloid 50 TSLP 50 ADAM# 50 gastrointestinal stromal tumors GISTs 50 pathogenetic 50 Galectins 50 susceptibility genes 50 amyloid pathology 50 systemic autoimmune 50 demyelinating disease 50 intestinal inflammation 50 neurodevelopmental 50 fatty acid oxidation 50 urea cycle 50 Lateral Sclerosis 50 Alzheimer disease frontotemporal dementia 50 genetic disorders 50 EGFR inhibitors 50 Epidermal Growth Factor Receptor 50 myelination 50 Maroteaux Lamy syndrome 50 antiproliferative effects 50 neuropsychiatric disorder 50 costimulatory 50 leukaemias 50 potent antiproliferative 50 biologic pathways 50 neurological disorder affecting 50 neural disorders 50 lipid synthesis 50 NLRP3 50 rheumatoid arthritis lupus 50 Akt signaling 50 signal transduction 50 Acute Lung 50 abnormal proteins 50 Hereditary angioedema 50 inflammatory autoimmune 50 neuropathic pain spasticity 50 cognitive impairment associated 50 dementias 50 systemic fungal infections 50 Crohns disease 50 PTP 1B 50 gene silencing 50 PPARγ 50 nerve cells 50 hyperammonemia 50 genomic variants 50 OPHN1 50 anticancer therapy 50 carcinoid 50 Injury ALI 50 prostaglandin synthesis 50 neoplastic 50 insulin resistance 50 Macular edema 50 glioma cells 50 sigma receptors 50 NF kB signaling 50 epigenetic mechanisms 50 NF KB 50 RAS RAF MEK 50 Chronic inflammation 50 Age Related Macular 50 degenerative retinal diseases 50 dystroglycan 50 receptor agonists 50 idiopathic pulmonary 50 channelopathies 50 ceroid lipofuscinosis NCL 50 mTOR mammalian target 50 TGF beta 50 amyloid protein plaques 50 TGF b 50 unknown etiology 50 ischemia reperfusion injury 50 neoplastic transformation 50 Neuroprotection 50 endoplasmic reticulum stress 50 cell adhesion molecule 50 biochemical pathway 50 PI3K Akt 50 pharmacological chaperone compounds 50 enzyme inhibitor 50 peroxisome 50 FLT3 50 SGLT2 50 cognitive disorders 50 Hsp# inhibitors 50 essential thrombocythemia 50 epigenetic modification 50 retinal diseases 50 Tumor Necrosis Factor 50 ERK pathway 50 Multiple sclerosis MS 50 ADPKD 50 histone deacetylases 50 microglial activation 50 cirrhosis liver failure 50 inherited mutations 50 chromosomal rearrangement 50 adipogenic 50 inflammatory cytokines 50 sporadic ALS 50 small molecule agonists 50 TGF ß 50 SOCS1 50 teplizumab 50 TLR8 50 NF kappa B 50 GRNCM1 50 therapeutics 50 NMDA receptor antagonist 50 #ME# 50 lymphotoxin 50 oxysterols 50 IL 1beta 50 serine proteases 50 oxidative damage 50 histone acetylation 50 Viprovex TM 50 glial scar 50 systemic lupus erythematosus 50 Hypoxia Inducible Factor 50 neuronal signaling 50 LHON 50 leukoencephalopathy PML 50 JAK2 50 small molecule 50 synapse formation 50 retinal ganglion cell 50 RNA interference 50 neuroprotective agent 50 neurofibromatosis type 50 TGF Beta 50 biochemical processes 50 Parkinson disease multiple sclerosis 50 catenin 50 tau proteins 50 myogenesis 50 senescent cells 50 tumor angiogenesis 50 idiopathic thrombocytopenic purpura 50 hypoxia inducible factor 50 glutamate signaling 50 aberrant activation 50 spinal muscular atrophy SMA 50 progressive neurologic 50 neurodevelopmental disorder 50 neovascularization 50 primary cilia 50 multifactorial disease 50 isoform selective 50 TNFAIP3 50 causative gene 50 KRAS oncogene 50 CCR3 50 poly ADP ribose polymerase 50 experimental autoimmune encephalomyelitis 49 ubiquitin ligases 49 receptor alpha 49 CB1 antagonists 49 rheumatoid arthritis 49 cell signaling pathway 49 Aurora kinase 49 complement inhibitor eculizumab 49 pro inflammatory cytokines 49 NF kappaB pathway 49 TNFalpha 49 neural stem cell 49 Carcinoid tumors 49 Idiopathic pulmonary fibrosis 49 molecular biomarkers 49 EGFR pathway 49 neuro degenerative 49 primary biliary cirrhosis 49 Gleevec resistant 49 GABAA receptors 49 HCV replication 49 choroidal vasculopathy 49 overactivation 49 induces apoptosis 49 PDGF receptor 49 N methyl 49 autoantigen 49 VEGF vascular endothelial 49 pro apoptotic 49 FTIs 49 inflammatory mediators 49 HCV protease 49 Stargardt Macular Dystrophy 49 Tβ4 49 divide uncontrollably 49 AKT1 49 protein biosynthesis 49 synaptic plasticity 49 amyloid beta peptides 49 inhibiting tumor 49 anticancer compounds 49 mitochondrial toxicity 49 nigrostriatal 49 Leber congenital amaurosis 49 ocular inflammatory 49 excitatory neurotransmitter glutamate 49 NF2 49 bone morphogenetic proteins 49 JAK inhibitors 49 filaggrin 49 potent anticancer 49 Factor Receptor 49 investigational therapies 49 PEDF 49 Th2 cytokines 49 PDE# 49 Myasthenia gravis 49 PI3 kinase 49 intracellular signal transduction 49 Amyloid plaques 49 BRAF protein 49 RNAi pathway 49 mitochondrial respiratory 49 dermatological disorders 49 cyclin E 49 TLR antagonists 49 acute leukemias 49 HSF1 49 rheumatoid arthritis gout 49 acinar cells 49 Six3 49 clioquinol 49 SIRT1 49 tumor suppressor 49 neuromuscular disorders 49 AAT Deficiency 49 hyperprolactinemia 49 activated microglia 49 stem cell differentiation 49 Fas ligand 49 lipid mediators 49 intracellular signaling pathways 49 NR2B 49 liver cancers hypercholesterolemia 49 gene transcription 49 RNA interference RNAi 49 Fibroblast 49 tumor metastasis 49 Autoimmune 49 INF2 49 Nrf2 49 lateral sclerosis ALS 49 dopaminergic neurons 49 NF1 49 CTLA 4 49 FGFR3 49 proteasome inhibitors 49 SOD1 protein 49 fibroblast growth 49 PTPN# 49 myelodysplastic syndrome MDS 49 vascular disrupting agents 49 factor HGF 49 Genetic variants 49 leukaemic stem cells 49 spontaneous mutations 49 MEK inhibitors 49 Aβ 49 demethylation 49 muscarinic 49 inflammatory autoimmune diseases 49 tafamidis 49 erythropoiesis 49 signaling pathways 49 glutamate 49 neural degeneration 49 spermidine 49 p# mutations 49 Ets2 49 Fabry Disease 49 oncoprotein 49 endotoxemia 49 arthritis lupus 49 chronic granulomatous disease 49 beta defensins 49 GRNOPC1 contains 49 transcriptional regulation 49 leukemia AML 49 Angelman syndrome 49 phosphatases 49 TNFα 49 immunoregulation 49 advanced glycation endproducts 49 monoclonal antibody therapeutics 49 mediated apoptosis 49 PAOD 49 traumatic spinal cord 49 metabolic enzymes 49 antisense inhibitors 49 Lafora disease 49 proteasome inhibitor 49 hematological malignancy 49 antisense oligonucleotides 49 antiphospholipid syndrome 49 melanocortin receptors 49 beta catenin 49 IGF1R 49 ACV1 49 beta globin gene 49 ocular diseases 49 endocannabinoids 49 CD#L 49 neurotoxicity 49 cardiovascular disorders 49 treating neuropathic pain 49 Skp2 49 GPCRs 49 systemic lupus erythematosus psoriasis 49 immune modulators 49 endocannabinoid signaling 49 Parkinson disease spinal cord 49 noncoding RNAs 49 genetically inherited 49 IGFBP2 49 fatal neuromuscular disorder 49 myelin repair 49 chromatin remodeling 49 ERK1 2 49 CHD7 49 mycosis fungoides 49 CDK inhibitors 49 mTOR signaling 49 histone methyltransferases HMTs